BLBD (Blue Bird Corporation Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by BLBD officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-20 | Daniel Mark Thau | Director | Buy | — | — |
| 2026-04-09 | Steve Girardin | Director | A | — | — |
| 2026-04-02 | Kevin S. Penn | Director | A | — | — |
| 2026-04-02 | Douglas J. Grimm | Director | A | — | — |
| 2026-04-02 | Mark Blaufuss | Director | A | — | — |
| 2026-04-02 | Julie A Fream | Director | A | — | — |
| 2026-04-02 | Simon J Newman | Director | A | — | — |
| 2026-04-02 | Edward T. Hightower | Director | A | — | — |
| 2026-04-02 | Daniel Mark Thau | Director | A | — | — |
| 2026-03-05 | Jeffrey Scott Sanfrey | Chief Operating Officer | MIXED | — | — |
| 2026-02-20 | Razvan Radulescu | Chief Financial Officer | Sell | — | — |
| 2025-12-17 | Razvan Radulescu | Chief Financial Officer | MIXED | — | — |
| 2025-12-16 | Jeffrey Scott Sanfrey | Chief Operating Officer | F | — | — |
| 2025-12-16 | Razvan Radulescu | Chief Financial Officer | F | — | — |
| 2025-12-16 | Phil Horlock | Director | Sell | — | — |
| 2025-12-16 | Ted Scartz | SVP General Counsel | F | — | — |
| 2025-12-10 | Razvan Radulescu | Chief Financial Officer | Sell | — | — |
| 2025-12-09 | Ted Scartz | SVP General Counsel | F | — | — |
| 2025-12-09 | Razvan Radulescu | Chief Financial Officer | F | — | — |
| 2025-12-09 | Jeffrey Scott Sanfrey | Chief Operating Officer | F | — | — |
| 2025-12-05 | Daniel Mark Thau | Director | Buy | — | — |
| 2025-12-04 | Ted Scartz | SVP General Counsel | MIXED | — | — |
| 2025-12-04 | Jeffrey Scott Sanfrey | Chief Operating Officer | MIXED | — | — |
| 2025-12-04 | Razvan Radulescu | Chief Financial Officer | MIXED | — | — |
| 2025-12-04 | John Wyskiel | President & CEO | MIXED | — | — |
| 2025-09-15 | Phil Horlock | Director | MIXED | — | — |
| 2025-09-03 | Razvan Radulescu | Chief Financial Officer | Sell | — | — |
| 2025-09-02 | Phil Horlock | Director | MIXED | — | — |
| 2025-08-19 | Phil Horlock | Director | MIXED | — | — |
| 2025-08-15 | Phil Horlock | Director | MIXED | — | — |
| 2025-08-14 | Ted Scartz | SVP General Counsel | MIXED | — | — |
| 2025-08-11 | Phil Horlock | Director | Sell | — | — |
| 2025-08-11 | Razvan Radulescu | Chief Financial Officer | Sell | — | — |
| 2025-08-08 | Razvan Radulescu | Chief Financial Officer | Sell | — | — |
| 2025-07-09 | Razvan Radulescu | Chief Financial Officer | Sell | — | — |
| 2025-07-03 | Razvan Radulescu | Chief Financial Officer | F | — | — |
| 2025-07-03 | Ted Scartz | SVP General Counsel | F | — | — |
| 2025-06-13 | Phil Horlock | Director | MIXED | — | — |
| 2025-06-11 | Phil Horlock | Director | MIXED | — | — |
| 2025-05-29 | Daniel Mark Thau | Director | Buy | — | — |
| 2025-04-03 | Phil Horlock | Director | A | — | — |
| 2025-04-03 | Daniel Mark Thau | Director | A | — | — |
| 2025-04-03 | Douglas J. Grimm | Director | A | — | — |
| 2025-04-03 | Kevin S. Penn | Director | A | — | — |
| 2025-04-03 | Edward T. Hightower | Director | A | — | — |
| 2025-04-03 | Mark Blaufuss | Director | A | — | — |
| 2025-04-03 | Julie A Fream | Director | A | — | — |
| 2025-04-03 | Simon J Newman | Director | A | — | — |
| 2025-03-04 | Phil Horlock | Director | F | — | — |
| 2025-02-20 | John Wyskiel | President & CEO | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 9,530,150 | — |
| — | 10%+ Owner | 6,542,650 | — |
| — | 10%+ Owner | 4,042,650 | — |
| — | Director | 2,373,195 | — |
| — | Director | 1,237,500 | — |
| — | Director | 969,246 | — |
| — | Director | 225,385 | — |
| — | President & CEO | 213,534 | — |
| — | President & CEO | 136,419 | — |
| — | Chief Financial Officer | 116,212 | — |
| — | President | 80,617 | — |
| — | Chief Adminstrative Officer | 61,050 | — |
| — | SVP General Counsel | 59,910 | — |
| — | Chief Operating Officer | 44,203 | — |
| — | Chief Financial Officer | 42,255 | — |
| — | Chief Commercial Officer | 38,055 | — |
| — | Chief Commercial Officer | 36,779 | — |
| — | Chief Operating Officer | 35,768 | — |
| — | Chief Operating Officer | 30,834 | — |
| — | General Counsel & Treasurer | 30,420 | — |
| — | Director | 29,991 | — |
| — | VP of Human Resources | 28,935 | — |
| — | Director | 28,764 | — |
| — | Director | 27,615 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the BLBD quote page; the site-wide leaderboard is on the insider transactions hub.